This archive covers progress stories and milestones from across Europe, spanning health, climate policy, social equity, and scientific research. From small-nation experiments to E.U.-wide initiatives, these reports highlight what is working and why.
Austria, Belgium, Denmark, Finland, Greece, Ireland, Luxembourg, Malta, the Netherlands, Portugal, Slovenia, Spain, Sweden, and the European Parliament have also applied to join the suit.
According to the airport, private and small business travel departing from Amsterdam emits around 20 times more climate-warming carbon dioxide per passenger than commercial aircraft.
With the Swiss national railway network stretching beyond 2,000 miles of track, estimates place the amount of power generation at potentially beyond 1 terawatt hour or 2% of the entire gross annual consumption.
More than 120 top attorneys have signed a declaration to “withhold services in respect of supporting new fossil fuel projects and action against climate protesters exercising their right to peaceful protest.”
Albania’s Vjosa River is now Europe’s first wild river national park, locking in permanent protection across 118 miles of one of the continent’s last large free-flowing rivers. The designation blocks 45 proposed hydropower dams that would have fragmented habitat for otters, Egyptian vultures, and the critically endangered Balkan lynx. It’s the result of nearly a decade of organizing by the Save the Blue Heart of Europe campaign, working alongside the Albanian government, the IUCN, and Patagonia, whose non-profit arm contributed $4.6 million. In a Europe crisscrossed by more than a million dams and weirs, the Vjosa offers a glimpse of what rivers once were — and a model other countries can follow as the world works toward protecting 30 percent of the planet by 2030.
Under the law, which is being hailed as the most ambitious maritime fuel legislation in the world, ship emissions will be reduced by 2% as of 2025 and 80% as of 2050.
Volkswagen announced a blockbuster investment in new EV and battery development that will greatly increase its North American manufacturing presence.
The Danish drugmaker will reduce the list price of its NovoLog insulin by 75%, and for Novolin and Levemir by 65%.
Bone cancer research has taken a meaningful step forward, with scientists identifying a single drug candidate that shows activity across all the major types of primary bone cancer — a group of diseases that have long resisted a unified treatment approach. Because these cancers disproportionately affect children and young people, the stakes are especially high. The compound appears to target something the different subtypes share biologically, which could open new research directions well beyond this one discovery. For pediatric cancer medicine, that kind of insight builds the foundation treatments are eventually made from.\n\nWord count: 88
NHS data suggests the gas, used to keep people unconscious during surgery, has a global warming potential 2,500 times greater than carbon dioxide.
